The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP49043-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to dicoumarol TSA211734-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol TSA211775-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol TSA211823-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol TSA211876-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol TSA211931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol TSA211984-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol TSA212037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol TSA212092-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol TSA212146-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol TSA212192-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol TSA212231-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol TSA212278-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol TSA212324-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol TSA212376-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol TSF492296-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF492297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF492293-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF492294-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF492295-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF492298-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF492593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF492588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF492589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF492590-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF492591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF492592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF598559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF598555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF598556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF598557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF598558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF598560-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF492896-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF492894-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF492895-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF492897-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF492898-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF492899-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF598891-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF598892-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF598893-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF598894-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF598895-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF598896-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF493227-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF493223-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF493224-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF493225-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF493226-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF493228-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF599227-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF599228-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF599231-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF599229-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF599230-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF599232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF493557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF493554-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF493555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF493556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF493558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF493559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF599566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF599563-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF599564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF599565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF599567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF599568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF493877-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF493873-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF493874-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF493878-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF493875-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF493876-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF599900-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF599899-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF599901-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF599903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF599902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF599904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF494205-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF494202-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF494206-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF494203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF494204-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF494207-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF600235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF600236-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF600237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF600238-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF600239-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF600240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF494537-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF494533-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF494534-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF494535-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF494538-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF494536-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF600570-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF600571-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF600572-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF600573-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF600574-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF600575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF494860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF494861-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF494859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF494862-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF494863-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF494864-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF600910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF600906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF600907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF600911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF600908-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF600909-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF495168-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF495165-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF495166-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF495167-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF495169-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF495170-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF601243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF601244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF601240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF601241-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF601242-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF601245-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF495485-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF495482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF495486-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF495483-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF495484-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF495487-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF601578-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF601574-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF601575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF601576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF601577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF601579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF495789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF495790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF495793-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF495791-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF495792-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF495794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF601910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF601913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF601911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF601912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF601914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF601915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF496102-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF496103-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF496104-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF496105-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF496106-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF496107-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF602249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF602246-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF602247-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF602248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF602250-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF602251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSF496430-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 10.0 µM for 24.0 h 1 subfactor(s) TSF496431-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 3.33 µM for 24.0 h 1 subfactor(s) TSF496432-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 1.11 µM for 24.0 h 1 subfactor(s) TSF496433-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.37 µM for 24.0 h 1 subfactor(s) TSF496434-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.125 µM for 24.0 h 1 subfactor(s) TSF496435-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.04 µM for 24.0 h 1 subfactor(s) TSF602580-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.74 µM for 24.0 h 1 subfactor(s) TSF602579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 2.22 µM for 24.0 h 1 subfactor(s) TSF602581-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.25 µM for 24.0 h 1 subfactor(s) TSF602582-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.08 µM for 24.0 h 1 subfactor(s) TSF602583-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.03 µM for 24.0 h 1 subfactor(s) TSF602584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.01 µM for 24.0 h 1 subfactor(s) TSS492305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.37 µM for 24.0 h TSS492306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.125 µM for 24.0 h TSS492302-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 10.0 µM for 24.0 h TSS492303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 3.33 µM for 24.0 h TSS492304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 1.11 µM for 24.0 h TSS492307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to dicoumarol 0.04 µM for 24.0 h TSS492602-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.04 µM for 24.0 h TSS492597-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 10.0 µM for 24.0 h TSS492598-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 3.33 µM for 24.0 h TSS492599-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 1.11 µM for 24.0 h TSS492600-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.37 µM for 24.0 h TSS492601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.125 µM for 24.0 h TSS598570-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.03 µM for 24.0 h TSS598566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 2.22 µM for 24.0 h TSS598567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.74 µM for 24.0 h TSS598568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.25 µM for 24.0 h TSS598569-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.08 µM for 24.0 h TSS598571-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to dicoumarol 0.01 µM for 24.0 h TSS492905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 1.11 µM for 24.0 h TSS492903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 10.0 µM for 24.0 h TSS492904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 3.33 µM for 24.0 h TSS492906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.37 µM for 24.0 h TSS492907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.125 µM for 24.0 h TSS492908-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.04 µM for 24.0 h TSS598902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 2.22 µM for 24.0 h TSS598903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.74 µM for 24.0 h TSS598904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.25 µM for 24.0 h TSS598905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.08 µM for 24.0 h TSS598906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.03 µM for 24.0 h TSS598907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to dicoumarol 0.01 µM for 24.0 h TSS493236-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.125 µM for 24.0 h TSS493232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 10.0 µM for 24.0 h TSS493233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 3.33 µM for 24.0 h TSS493234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 1.11 µM for 24.0 h TSS493235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.37 µM for 24.0 h TSS493237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.04 µM for 24.0 h TSS599238-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 2.22 µM for 24.0 h TSS599239-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.74 µM for 24.0 h TSS599242-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.03 µM for 24.0 h TSS599240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.25 µM for 24.0 h TSS599241-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.08 µM for 24.0 h TSS599243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to dicoumarol 0.01 µM for 24.0 h TSS493566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.37 µM for 24.0 h TSS493563-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 10.0 µM for 24.0 h TSS493564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 3.33 µM for 24.0 h TSS493565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 1.11 µM for 24.0 h TSS493567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.125 µM for 24.0 h TSS493568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.04 µM for 24.0 h TSS599577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.08 µM for 24.0 h TSS599574-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 2.22 µM for 24.0 h TSS599575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.74 µM for 24.0 h TSS599576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.25 µM for 24.0 h TSS599578-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.03 µM for 24.0 h TSS599579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to dicoumarol 0.01 µM for 24.0 h TSS493886-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.125 µM for 24.0 h TSS493882-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 10.0 µM for 24.0 h TSS493883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 3.33 µM for 24.0 h TSS493887-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.04 µM for 24.0 h TSS493884-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 1.11 µM for 24.0 h TSS493885-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.37 µM for 24.0 h TSS599911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.74 µM for 24.0 h TSS599910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 2.22 µM for 24.0 h TSS599912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.25 µM for 24.0 h TSS599914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.03 µM for 24.0 h TSS599913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.08 µM for 24.0 h TSS599915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to dicoumarol 0.01 µM for 24.0 h TSS494214-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.37 µM for 24.0 h TSS494211-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 10.0 µM for 24.0 h TSS494215-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.125 µM for 24.0 h TSS494212-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 3.33 µM for 24.0 h TSS494213-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 1.11 µM for 24.0 h TSS494216-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.04 µM for 24.0 h TSS600246-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 2.22 µM for 24.0 h TSS600247-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.74 µM for 24.0 h TSS600248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.25 µM for 24.0 h TSS600249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.08 µM for 24.0 h TSS600250-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.03 µM for 24.0 h TSS600251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to dicoumarol 0.01 µM for 24.0 h TSS494546-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.125 µM for 24.0 h TSS494542-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 10.0 µM for 24.0 h TSS494543-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 3.33 µM for 24.0 h TSS494544-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 1.11 µM for 24.0 h TSS494547-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.04 µM for 24.0 h TSS494545-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.37 µM for 24.0 h TSS600581-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 2.22 µM for 24.0 h TSS600582-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.74 µM for 24.0 h TSS600583-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.25 µM for 24.0 h TSS600584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.08 µM for 24.0 h TSS600585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.03 µM for 24.0 h TSS600586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to dicoumarol 0.01 µM for 24.0 h TSS494869-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 3.33 µM for 24.0 h TSS494870-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 1.11 µM for 24.0 h TSS494868-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 10.0 µM for 24.0 h TSS494871-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.37 µM for 24.0 h TSS494872-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.125 µM for 24.0 h TSS494873-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.04 µM for 24.0 h TSS600921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.03 µM for 24.0 h TSS600917-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 2.22 µM for 24.0 h TSS600918-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.74 µM for 24.0 h TSS600922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.01 µM for 24.0 h TSS600919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.25 µM for 24.0 h TSS600920-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to dicoumarol 0.08 µM for 24.0 h TSS495177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.37 µM for 24.0 h TSS495174-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 10.0 µM for 24.0 h TSS495175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 3.33 µM for 24.0 h TSS495176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 1.11 µM for 24.0 h TSS495178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.125 µM for 24.0 h TSS495179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.04 µM for 24.0 h TSS601254-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.08 µM for 24.0 h TSS601255-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.03 µM for 24.0 h TSS601251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 2.22 µM for 24.0 h TSS601252-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.74 µM for 24.0 h TSS601253-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.25 µM for 24.0 h TSS601256-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to dicoumarol 0.01 µM for 24.0 h TSS495494-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.37 µM for 24.0 h TSS495491-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 10.0 µM for 24.0 h TSS495495-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.125 µM for 24.0 h TSS495492-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 3.33 µM for 24.0 h TSS495493-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 1.11 µM for 24.0 h TSS495496-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.04 µM for 24.0 h TSS601589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.03 µM for 24.0 h TSS601585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 2.22 µM for 24.0 h TSS601586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.74 µM for 24.0 h TSS601587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.25 µM for 24.0 h TSS601588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.08 µM for 24.0 h TSS601590-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to dicoumarol 0.01 µM for 24.0 h TSS495798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 10.0 µM for 24.0 h TSS495799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 3.33 µM for 24.0 h TSS495802-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.125 µM for 24.0 h TSS495800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 1.11 µM for 24.0 h TSS495801-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.37 µM for 24.0 h TSS495803-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.04 µM for 24.0 h TSS601921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 2.22 µM for 24.0 h TSS601924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.08 µM for 24.0 h TSS601922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.74 µM for 24.0 h TSS601923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.25 µM for 24.0 h TSS601925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.03 µM for 24.0 h TSS601926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to dicoumarol 0.01 µM for 24.0 h TSS496111-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 10.0 µM for 24.0 h TSS496112-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 3.33 µM for 24.0 h TSS496113-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 1.11 µM for 24.0 h TSS496114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.37 µM for 24.0 h TSS496115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.125 µM for 24.0 h TSS496116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.04 µM for 24.0 h TSS602260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.08 µM for 24.0 h TSS602257-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 2.22 µM for 24.0 h TSS602258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.74 µM for 24.0 h TSS602259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.25 µM for 24.0 h TSS602261-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.03 µM for 24.0 h TSS602262-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to dicoumarol 0.01 µM for 24.0 h TSS496439-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 10.0 µM for 24.0 h TSS496440-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 3.33 µM for 24.0 h TSS496441-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 1.11 µM for 24.0 h TSS496442-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.37 µM for 24.0 h TSS496443-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.125 µM for 24.0 h TSS496444-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.04 µM for 24.0 h TSS602591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.74 µM for 24.0 h TSS602590-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 2.22 µM for 24.0 h TSS602592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.25 µM for 24.0 h TSS602593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.08 µM for 24.0 h TSS602594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.03 µM for 24.0 h TSS602595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to dicoumarol 0.01 µM for 24.0 h
TSP49043 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to dicoumarol
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided